Stem Cell Eye 'Patch' To Save Sight Gets Cash Boost, Pfizer Inc. To Start Clinical Trails With University College London

Bookmark and Share

New Scientist -- A small patch of cells that protects the eye from age-related blindness could begin trials in patients within two years in the UK. The pioneering treatment could be one of the first successful applications originating from embryonic stem cells (ESC), the cells in embryos that can grow into all tissues of the body.

Back to news